38. T. L. Horvath, S. Diano, Nat. Rev. Neurosci. 5, 662 (2004 Hypothalamic neurons that express neuropeptide Y (NPY) and agouti-related protein (AgRP) are thought to be critical regulators of feeding behavior and body weight. To determine whether NPY/AgRP neurons are essential in mice, we targeted the human diphtheria toxin receptor to the Agrp locus, which allows temporally controlled ablation of NPY/AgRP neurons to occur after an injection of diphtheria toxin. Neonatal ablation of NPY/AgRP neurons had minimal effects on feeding, whereas their ablation in adults caused rapid starvation. These results suggest that network-based compensatory mechanisms can develop after the ablation of NPY/AgRP neurons in neonates but do not readily occur when these neurons become essential in adults.
The arcuate nucleus (ARC) of the hypothalamus is a site of convergence of central and peripheral signals of energy stores, and it contains at least two distinct populations of neurons that are critically involved in the regulation of body weight (1) (2) (3) . Orexigenic neuropeptide Y/agouti-related protein (NPY/AgRP) neurons and anorexigenic pro-opiomelanocortin (POMC) neurons respond to circulating satiety and hunger signals, including glucose, leptin, insulin, ghrelin, and peptide YY (4, 5) . Both populations exert an inhibitory tone onto each other, and they also send dense projections to other hypothalamic areas, including the paraventricular nucleus (PVN), zona incerta, perifornical area, and lateral hypothalamic area (6, 7) . POMC neurons reduce food intake and increase energy expenditure by releasing amelanocyte-stimulating hormone (aMSH), a product of POMC processing, which activates melanocortin-4 receptors (MC4R). NPY/AgRP neurons have the opposite effects, inhibiting POMC neurons and antagonizing the action of aMSH on MC4R-bearing cells via the release of AgRP (a natural antagonist of aMSH) (8) .
Despite the fact that intracranial injection of either NPY or AgRP stimulates robust feeding in rodents (1-3), mutations that prevent the expression of AgRP, NPY, or various receptors for NPY have little impact on feeding behavior (3, (9) (10) (11) . In contrast, mutations that prevent production of leptin, leptin receptor, POMC, or MC4R lead to obesity in mice and other species (12) (13) (14) (15) (16) (17) . These observations raise the question of whether signaling by NPY, AgRP, or any other transmitter made by these cells is important for the regulation of body weight. To assess whether NPY/AgRP neurons are essential for feeding, we adopted a Btoxin receptor-mediated cell knockout[ strategy (18) to specifically ablate these neurons in a temporally controlled manner (19) . Because Agrp gene expression is restricted to NPY/AgRP neurons in the brain (20, 21) , we targeted the expression of the human diphtheria toxin receptor cDNA (DTR) to the Agrp locus in embryonic stem cells and generated Agrp DTR/þ mice that express the human DTR in NPY/AgRP neurons ( fig. S1 ). In situ hybridization revealed that human DTR mRNA was expressed in the ARC of Agrp DTR/þ mice but not in controls ( fig. S2 ).
Neonatal ablation of NPY/AgRP neurons was performed by injecting 1-day-old Agrp DTR/þ and control Agrp þ/þ pups (genotype unknown at time of injection) with diphtheria toxin (DT) at 50 mg of DT per kg mouse (mg/kg) (subcutaneous), a dose tolerated by controls (18, 21) . After 9 weeks, all mice were fasted for 2 days to increase NPY and AgRP expression before they were killed (22) . Brains were fixed, sectioned, and analyzed for NPY expression by immunohistochemistry. DT injection reduced the number of NPY-positive cells in the ARC by È85% (Agrp DTR/þ mice had 9.7 T 0.9 neurons per section, n 0 5 mice; controls had 78 T 2 neurons per section, n 0 3, P G 0.001) ( (Fig. 1I) .
If NPY/AgRP neurons are critical regulators of energy balance, then their ablation should negatively affect food intake and body weight. However, when newborn pups generated from a cross of Agrp DTR/þ and Agrp þ/þ mice were injected with DT and their body weights recorded starting at weaning, there was only a slight (È11%) reduction in the body weight of Agrp DTR/þ mice compared with controls ( fig. S4) . Food consumption by 9-week-old littermates was monitored using Blickometer[ cages that dispensed water and liquid food. The number of licks and total food consumption were the same for both groups of mice, either before or after a 12-hour fast ( Fig.  2A) . At the end of each experiment, the depletion of NPY immunoreactivity in the ARC was verified. Similar results were obtained when either Agrp DTR/þ or Agrp DTR/DTR neonatal mice (up to 8 days old) were injected either once or twice with DT at 50 mg/kg (i.e., the survival of DT-injected mice to adulthood was independent of genotype, n 9 100). These results indicate that the majority (approaching 100% in some cases) ( fig. S3 ) of NPY/AgRP cells in the ARC can be ablated in neonatal mice with little impact on food consumption or body weight.
We also examined the effects of administering DT to adult Agrp þ/þ , Agrp DTR/þ , or Agrp DTR/DTR mice (table S1). Adult mice were allowed to acclimate to lickometer cages for several days and then two intraperitoneal (ip) injections of DT (50 mg/kg, 3 days apart) were administered. There was an irreversible arrest of feeding after the second injection of DT into Agrp DTR/DTR mice but not into controls (Fig. 2B) . All Agrp DTR/DTR mice treated this way lost È20% of their body weight within 2 days of the second injection and were killed for immunohistochemical detection of NPY/AgRP neurons, which were always depleted by 980%. Injection of adult heterozygous Agrp DTR/þ mice with DT (either once or twice) also terminated feeding (table S1). The loss of AgRP-producing cells was also measured by semiquantitative RT-PCR in Agrp DTR/þ mice, which revealed a comparable loss of AgRP transcripts in neonatal and adult mice treated with DT. Occasionally, control mice also succumbed from this treatment, probably because of nonspecific toxicity associated with ip administration of DT. Intramuscular (im) injection of DT in adult mice produced more reliable responses compared with ip injection (18) . Littermates (Agrp þ/þ or Agrp DTR/DTR ) received either one injection of DT (50 mg/kg, im), or two injections, 2 days apart. The consumption of liquid food by DT-treated Agrp DTR/DTR mice fell below 20% of normal 7 days after a single injection of DT or within 5 days with two injections (Fig. 3, A and C, and fig. S5 ). At these time points, all Agrp DTR/DTR mice lost È20% of their body weight and had to be euthanized, whereas control mice maintained body weight and survived (Fig. 3, B and D, and table S1 ). Water consumption increased in Agrp DTR/DTR mice after DT injections, demonstrating that the reduction in food intake was not due to an inability to reach the feeding tubes or to lick. Hand feeding via oral gavage with liquid food could sustain DT-treated mice, confirming that the lack of feeding was responsible for their loss of body weight. NPY immunostaining of sections through the ARC confirmed that most NPY/AgRP cell bodies were ablated from the ARC of Agrp DTR/DTR mice (Fig. 3, E and F). The number of NPY fibers in the PVN was also reduced in Agrp DTR/DTR mice compared with controls (Fig. 3, I to L). The number of POMC neurons was normal, but the ACTH staining appeared to be more robust in the Agrp DTR/DTR mice treated with DT (Fig. 3,  G and H) , which is consistent with the loss of NPY/AgRP inhibitory input onto POMC cells.
To demonstrate that loss of feeding is the consequence of central action of DT, the toxin was delivered to the third ventricle of Agrp DTR/DTR mice. All injected Agrp DTR/DTR mice stopped eating, whereas controls were unaffected (table S1) .
Agrp DTR/þ or Agrp DTR/DTR neonates survived all of the DT treatments that led to starvation in adults, despite comparable ablation of NPY/AgRP neurons, which suggests that some form of compensation occurs in neonates. Perhaps residual neonatal NPY/AgRP neurons can enhance their signaling better than can adult neurons, or DTR-expressing cells may continue to be born after neonatal DT injection, allowing survival. These explanations predict that mice treated neonatally with DT would be susceptible to DT exposure as adults. However, most (5 of 7) mice injected with DT as neonates survived when DT was injected in the third ventricle as adults ( fig. S6 ). Ventricular injection of DT was used to minimize potential immune responses to prior DT exposure; however, in agreement with others (23), neonatal exposure to DT generates minimal neutralizing antibody ( fig. S7) . In another experiment, most (5 of 8) neonatally treated Agrp DTR/DTR mice survived im injection of DT (50 mg/kg) as adults. The fractional survival of doubly exposed Agrp DTR/DTR mice suggests alternate modes of compensation (24) .
The ablation of NPY/AgRP neurons in neonates is not only tolerated but produces compensatory changes that allow almost normal growth and feeding in the adult. Nevertheless, we predict that hormonal or metabolic signals that depend on NPY/AgRP neurons, e.g., ghrelin (25) , may be compromised. The melanocortin signaling pathway, which is important for body-weight regulation in adults, may not be critical for feeding by neonates. Thus, ablating NPY/AgRP neurons before the POMC cells become critical may allow development of a network-based compensatory mechanism. Changes in synapses within the ARC after restoration of leptin to young Lep ob/ob mice illustrate one form of plasticity that can occur in the hypothalamus (26, 27) . Presumably, the loss of signaling molecules made by NPY/AgRP neurons initiates the compensatory adaptations in neonates, but the nature of those signals and the identity of the cells that respond remain to be discovered. This adaptation could explain why conventional inactivation of Npy and/or Agrp genes has little effect on bodyweight regulation (10, 11) .
The NPY/AgRP neurons in the ARC become a critical component of the feeding neurocircuitry sometime between 8 and 45 days after birth. By this time, the melanocortin signaling pathway is established; hence, ablation of NPY/AgRP neurons may remove a critical inhibitory tone, leading to excessive melanocortin signaling and starvation. However, NPY/AgRP neurons project widely (19) , so their ablation in the adult may perturb other critical signaling pathways, resulting in starvation.
Note added in proof: Two related papers (28, 29) were published online while this Report was under review. In both cases, the authors report that partial ablation of NPY/AgRP neurons results in smaller mice that eat less than controls do. The partial ablation is probably the consequence of gradual ablation or partial penetrance of transgene expression. Neither paper describes the starvation phenotype nor the neonatal compensation reported here. 
